First Time Loading...

Chugai Pharmaceutical Co Ltd
TSE:4519

Watchlist Manager
Chugai Pharmaceutical Co Ltd Logo
Chugai Pharmaceutical Co Ltd
TSE:4519
Watchlist
Price: 5 094 JPY 1.35% Market Closed
Updated: May 5, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Income Statement

1.1T
-13%
Revenue
Growth Rates:
1 Year
-12%
3 Years
+41%
5 Years
+92%
7 Years
+126%
10 Years
+162%
444.2B
-6%
Operating Income
Growth Rates:
1 Year
-17%
3 Years
+47%
5 Years
+257%
7 Years
+478%
10 Years
+464%
325.5B
-3%
Net Income
Growth Rates:
1 Year
-13%
3 Years
+52%
5 Years
+252%
7 Years
+507%
10 Years
+539%

Earnings Waterfall
Chugai Pharmaceutical Co Ltd

Revenue
1.1T JPY
Cost of Revenue
-413.3B JPY
Gross Profit
698.1B JPY
Operating Expenses
-253.8B JPY
Operating Income
444.2B JPY
Other Expenses
-118.8B JPY
Net Income
325.5B JPY

Income Statement
Chugai Pharmaceutical Co Ltd

Rotate your device to view
Income Statement
Currency: JPY
Dec-2013 Mar-2014 Jun-2014 Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023
Revenue
Revenue
423 652
N/A
457 281
+8%
444 658
-3%
450 546
+1%
461 109
+2%
454 147
-2%
479 265
+6%
495 454
+3%
498 840
+1%
501 650
+1%
506 193
+1%
492 585
-3%
491 781
0%
497 355
+1%
497 024
0%
517 909
+4%
534 199
+3%
556 158
+4%
566 547
+2%
572 994
+1%
579 787
+1%
586 649
+1%
614 950
+5%
662 198
+8%
686 184
+4%
711 320
+4%
734 019
+3%
753 853
+3%
786 946
+4%
776 339
-1%
809 054
+4%
887 918
+10%
999 759
+13%
1 191 495
+19%
1 205 696
+1%
1 143 716
-5%
1 259 726
+10%
1 211 632
-4%
1 243 437
+3%
1 276 050
+3%
1 111 367
-13%
Gross Profit
Cost of Revenue
(186 977)
(201 696)
(201 263)
(211 115)
(218 076)
(220 314)
(232 689)
(239 469)
(240 238)
(243 680)
(248 031)
(245 378)
(247 944)
(247 929)
(244 359)
(250 590)
(254 171)
(256 834)
(261 796)
(262 676)
(262 847)
(262 925)
(261 758)
(269 834)
(264 732)
(263 434)
(269 931)
(265 269)
(273 465)
(267 530)
(265 020)
(299 856)
(337 680)
(397 233)
(408 997)
(373 899)
(476 251)
(513 156)
(524 995)
(534 155)
(413 306)
Gross Profit
236 675
N/A
255 585
+8%
243 395
-5%
239 431
-2%
243 033
+2%
233 833
-4%
246 576
+5%
255 985
+4%
258 602
+1%
257 970
0%
258 162
+0%
247 207
-4%
243 837
-1%
249 426
+2%
252 665
+1%
267 319
+6%
280 028
+5%
299 324
+7%
304 751
+2%
310 318
+2%
316 940
+2%
323 724
+2%
353 192
+9%
392 364
+11%
421 452
+7%
447 886
+6%
464 088
+4%
488 584
+5%
513 481
+5%
508 809
-1%
544 034
+7%
588 062
+8%
662 079
+13%
794 262
+20%
796 699
+0%
769 817
-3%
783 475
+2%
698 476
-11%
718 442
+3%
741 895
+3%
698 061
-6%
Operating Income
Operating Expenses
(157 937)
(160 421)
(159 660)
(159 718)
(167 174)
(168 313)
(170 624)
(172 202)
(171 818)
(171 883)
(171 075)
(168 847)
(166 953)
(166 250)
(172 193)
(172 837)
(181 094)
(188 373)
(186 349)
(189 705)
(192 617)
(191 669)
(200 386)
(205 075)
(206 939)
(210 972)
(207 914)
(211 546)
(211 298)
(216 022)
(222 754)
(231 315)
(233 840)
(249 325)
(248 533)
(246 921)
(249 533)
(249 228)
(256 279)
(269 771)
(253 835)
Selling, General & Administrative
(83 657)
(84 336)
(83 535)
(84 305)
(86 374)
(86 853)
(87 367)
(86 211)
(88 018)
(87 772)
(86 313)
(85 480)
(81 941)
(81 247)
(82 463)
(82 410)
(88 147)
(89 630)
(89 710)
(91 553)
(93 416)
(92 379)
(97 894)
(99 844)
(100 676)
(102 068)
(96 920)
(95 498)
(92 992)
(94 547)
(96 491)
(98 993)
(100 754)
(107 888)
(106 840)
(104 721)
(99 589)
(96 520)
(107 753)
(112 702)
(111 916)
Research & Development
(74 281)
(76 088)
(76 125)
(75 413)
(80 800)
(81 459)
(83 257)
(85 990)
(83 799)
(84 111)
(84 761)
(83 366)
(85 011)
(85 000)
(89 728)
(90 426)
(92 947)
(98 743)
(96 638)
(98 150)
(99 202)
(99 289)
(102 491)
(105 231)
(104 733)
(108 903)
(110 995)
(116 049)
(116 601)
0
(96 538)
(102 597)
(131 276)
(141 438)
(141 694)
(142 201)
(148 061)
(153 976)
(164 487)
(173 192)
(169 111)
Depreciation & Amortization
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(1 530)
0
0
0
(1 705)
0
0
0
(1 810)
0
0
0
(1 820)
0
0
0
(1 369)
Other Operating Expenses
0
3
0
0
0
0
0
(1)
(1)
0
(1)
(1)
(1)
(3)
(2)
(1)
0
0
(1)
(2)
1
0
(2)
(1)
0
0
1
0
0
(121 475)
(29 725)
(29 725)
0
0
1
0
(63)
1 268
15 961
16 123
28 561
Operating Income
78 738
N/A
95 164
+21%
83 735
-12%
79 713
-5%
75 859
-5%
65 520
-14%
75 952
+16%
83 783
+10%
86 784
+4%
86 087
-1%
87 087
+1%
78 360
-10%
76 884
-2%
83 176
+8%
80 472
-3%
94 482
+17%
98 934
+5%
110 951
+12%
118 402
+7%
120 613
+2%
124 323
+3%
132 055
+6%
152 806
+16%
187 289
+23%
214 513
+15%
236 914
+10%
256 174
+8%
277 038
+8%
302 183
+9%
292 787
-3%
321 280
+10%
356 747
+11%
428 239
+20%
544 937
+27%
548 166
+1%
522 896
-5%
533 942
+2%
449 248
-16%
462 163
+3%
472 124
+2%
444 226
-6%
Pre-Tax Income
Interest Income Expense
(1 794)
(616)
(303)
(72)
304
554
628
350
555
149
135
584
1 262
632
468
318
4
8
35
(74)
444
609
614
406
519
(407)
1
(523)
(1 575)
(606)
(777)
403
56
1 355
1 819
(363)
769
(242)
365
3 008
4 240
Non-Reccuring Items
0
0
0
0
0
0
0
0
(64)
0
0
0
(160)
0
0
0
(97)
0
0
0
0
0
0
0
(3 916)
0
0
0
(953)
0
0
0
(6 342)
0
0
0
(633)
(4 651)
(4 892)
(5 052)
(5 052)
Total Other Income
1
(1)
0
1
1
0
1
2
1
(1)
1
0
(3 538)
(4 539)
(3 884)
(4 558)
(1 810)
(1 230)
(2 817)
(2 729)
(3 318)
(3 447)
(3 186)
(3 300)
(3 223)
(2 820)
(2 498)
(2 062)
(1 467)
(968)
(625)
(3 155)
(2 568)
(4 941)
(4 936)
(2 142)
(2 912)
268
268
267
407
Pre-Tax Income
76 944
N/A
94 547
+23%
83 433
-12%
79 642
-5%
76 164
-4%
66 075
-13%
76 581
+16%
84 134
+10%
87 276
+4%
86 236
-1%
87 223
+1%
78 945
-9%
74 448
-6%
79 269
+6%
77 056
-3%
90 242
+17%
97 031
+8%
109 729
+13%
115 620
+5%
117 810
+2%
121 449
+3%
129 217
+6%
150 234
+16%
184 395
+23%
207 893
+13%
233 687
+12%
253 677
+9%
274 453
+8%
298 188
+9%
291 213
-2%
319 878
+10%
353 995
+11%
419 385
+18%
541 351
+29%
545 049
+1%
520 391
-5%
531 166
+2%
444 623
-16%
457 904
+3%
470 347
+3%
443 821
-6%
Net Income
Tax Provision
(25 058)
(32 771)
(27 383)
(26 165)
(24 087)
(18 258)
(23 133)
(24 048)
(24 923)
(24 009)
(23 645)
(21 472)
(20 076)
(20 864)
(18 169)
(21 721)
(23 490)
(26 760)
(29 566)
(31 248)
(28 370)
(29 260)
(36 947)
(44 792)
(50 333)
(59 625)
(63 080)
(71 864)
(83 455)
(80 603)
(89 301)
(97 533)
(116 390)
(153 991)
(156 037)
(149 600)
(156 737)
(128 468)
(130 934)
(133 602)
(118 349)
Income from Continuing Operations
51 886
61 776
56 050
53 477
52 077
47 817
53 448
60 086
62 353
62 227
63 578
57 473
54 372
58 405
58 887
68 521
73 541
82 969
86 054
86 562
93 079
99 957
113 287
139 603
157 560
174 062
190 597
202 589
214 733
210 610
230 577
256 462
302 995
387 360
389 012
370 791
374 429
316 155
326 970
336 745
325 472
Income to Minority Interest
(991)
(1 002)
(1 005)
(1 016)
(1 097)
(1 030)
(1 227)
(1 189)
(1 228)
(1 184)
(1 040)
(908)
(780)
(811)
(744)
(817)
(827)
(868)
(767)
(704)
(591)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Net Income (Common)
50 895
N/A
60 774
+19%
55 045
-9%
52 461
-5%
50 980
-3%
46 786
-8%
52 220
+12%
58 897
+13%
61 125
+4%
61 043
0%
62 537
+2%
56 562
-10%
53 592
-5%
57 592
+7%
58 142
+1%
67 704
+16%
72 713
+7%
82 101
+13%
85 287
+4%
85 858
+1%
92 488
+8%
99 632
+8%
113 071
+13%
139 544
+23%
157 560
+13%
174 063
+10%
190 598
+9%
202 590
+6%
214 733
+6%
210 611
-2%
230 578
+9%
256 463
+11%
302 995
+18%
387 360
+28%
389 012
+0%
370 791
-5%
374 429
+1%
316 154
-16%
326 969
+3%
336 745
+3%
325 472
-3%
EPS (Diluted)
93.38
N/A
111.3
+19%
100.81
-9%
96.08
-5%
93.38
-3%
85.53
-8%
95.46
+12%
107.67
+13%
37.26
-65%
111.61
+200%
114.33
+2%
103.41
-10%
32.66
-68%
105.28
+222%
106.29
+1%
123.77
+16%
44.28
-64%
149.81
+238%
155.63
+4%
156.67
+1%
56.27
-64%
60.59
+8%
68.76
+13%
84.84
+23%
95.81
+13%
105.83
+10%
115.87
+9%
123.15
+6%
130.53
+6%
128.02
-2%
140.15
+9%
155.88
+11%
184.17
+18%
235.44
+28%
236.5
+0%
225.39
-5%
227.57
+1%
192.14
-16%
198.71
+3%
204.63
+3%
197.8
-3%

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 134,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.